Jab for joy.
Researchers have discovered that semaglutide weight loss drugs like Ozempic may reduce the risk of early-onset colorectal cancer (CRC) in diabetes patients.
Colon cancer has long been associated with older adults, especially people over 65. However, colorectal cancer rates have been steadily increasing among adults under 50 since the ’90s.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
